Orange Book Blog

Law Seminars International has announced that it will hold “a comprehensive two-day conference on licensing, life-cycle management, and M&A issues in the field of pharmaceutical antitrust,” April 26-27, 2007, at the Capital Hilton in Washington, D.C.  The conference will feature a special address by FTC Commissioner J. Thomas Rosch and presentations by six other federal and state enforcers.

With health care costs rising and political pressure mounting, Congress has proposed new laws to prevent “reverse payment” settlements of Hatch-Waxman cases, to ban authorized generics, and to stem abuse of the FDA citizen petition process.  LSI’s Pharmaceutical Antitrust conference will address these hot issues and more.  The following sessions look particularly interesting:

• Recent Pharmaceutical Antitrust Cases and Enforcement Initiatives
• Pricing and Distribution Agreements: Maximizing Flexibility While Controlling Risk
• The Regulators Speak: Discussion of Important Enforcement Developments and Initiatives
• Maximizing the Life-Cycle of Products
• Settling Pharmaceutical Patent Disputes

David A. Balto, Esq., Jeffrey W. Brennan, Esq., and George Frank, Ph.D., Esq. are the program co-chairs of the conference.  Additional details, as well as registration information, are available on the conference website.

Orange Book Blog is a media partner of this conference.